Riccardo Saccardi, MD, Careggi University Hospital, Florence, Italy, debates on whether CAR-T cells are replacing autologous stem cell transplantation (autoSCT) in the treatment of autoimmune diseases, referring to various disease phenotypes. This interview took place at The 8th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2023), held in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.